Skip to main content

Table 2 The hematological parameters of the tumor-bearing mice with different treatments. (n = 5)

From: αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma

Parameters

RBCa (× 1012/L)

WBCb (× 109/L)

ALTc [U/L]

Crd [μmol/L]

Groups

    

Control

10.00 ± 0.76

5.12 ± 0.56

65.97 ± 5.03

20.90 ± 1.98

cRGD-Exo

10.52 ± 0.83

5.46 ± 0.47

66.43 ± 5.83

20.77 ± 2.05

TP solution

8.11 ± 0.65**

6.73 ± 0.51**

76.25 ± 4.03*

27.76 ± 1.52**

Exo/TP

10.31 ± 0.62

4.92 ± 0.38

66.92 ± 2.47

19.63 ± 0.80

cRGD-Exo/TP

10.07 ± 0.68

5.55 ± 0.31

63.19 ± 3.54

20.41 ± 1.69

  1. aRed blood cell
  2. bwhite blood cell
  3. calanine aminotransferase
  4. dcreatinine
  5. *p < 0.05
  6. **p < 0.01 versus the control